Filing Details

Accession Number:
0000313143-11-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-04 16:46:28
Reporting Period:
2011-05-04
Filing Date:
2011-05-04
Accepted Time:
2011-05-04 16:46:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
313143 Haemonetics Corp HAE Surgical & Medical Instruments & Apparatus (3841) 042882273
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1266051 J Christopher Lindop 400 Wood Road
Braintree MA 02184
Cfo &Amp Vice President Of No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-04 273 $46.80 11,370 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-Qualified Stock Option (right to buy) $48.09 2008-01-25 2014-01-25 40,545 40,545 Direct
Common Stock Non-Qualified Stock Option (right to buy) $51.07 2008-10-24 2014-10-24 21,238 21,238 Direct
Common Stock Non-Qualified Stock Option (right to buy) $52.63 2009-10-23 2015-10-23 49,020 49,020 Direct
Common Stock Non-Qualified Stock Option (right to buy) $52.94 2010-10-27 2016-10-27 22,036 22,036 Direct
Common Stock Non-Qualified Stock Option (right to buy) $54.55 2009-10-22 2015-10-22 21,441 21,441 Direct
Common Stock Non-Qualified Stock Option (right to buy) $54.99 2011-10-27 2017-10-27 25,095 25,095 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2014-01-25 40,545 40,545 Direct
2014-10-24 21,238 21,238 Direct
2015-10-23 49,020 49,020 Direct
2016-10-27 22,036 22,036 Direct
2015-10-22 21,441 21,441 Direct
2017-10-27 25,095 25,095 Direct
Footnotes
  1. Acquisition of shares of Common Stock pursuant to the Employee Stock Purchase Plan. Participant elected to purchase shares at least six months in advance of the effective date of the transaction.
  2. Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
  3. Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
  4. Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.